|
Post by lakon on May 10, 2016 11:11:21 GMT -5
|
|
|
Post by patten1962 on May 10, 2016 11:13:22 GMT -5
Are you saying this is a good thing?
|
|
|
Post by lakon on May 10, 2016 11:46:35 GMT -5
It could be good. It could be bad. I am just wondering who it is and hoping we learn sooner rather than later. It could be the backers of RLS, but they don't want to be known so that would be unlikely unless they have a way to avoid revealing themselves. On the other hand, maybe they are ready for the big reveal. I don't know if Al Mann's estate had any vehicle to act as an institutional investor. I thought that there is an obscure rule that might allow a billionaire's home office to count, but really need to refresh my regulatory chops on these oddities. As others noted, short interests, or their handlers [GS], could use this as an easy option to close out positions and GO LONG. Yet, MNKD has a history of favoring options that fail to help the shorts, if possible, with the exception of a falling stock price. They don't seem to mind that too much. What else? Who else?
|
|
|
Post by dg1111 on May 10, 2016 11:56:59 GMT -5
Reading the 8-K, it appears that specific buyer(s) are lined up. I was worried last night that there may not be buyers, and things would get worse. This should give enough cash to allow the sales to start to pick up towards the end of the year. It wasn't the best thing that could happen, but I don't think it's all that bad.
|
|
|
Post by als57 on May 10, 2016 12:21:37 GMT -5
Betting my hat, ass and overcoat that the purchaser is Bank of America! They have danced with Mannkind before and "screwed" the shareholders, so its like in football, keep running the same play until the other side stops you.
To me, what transpired at and after the CC, indicates that the end is near. All of Matt's plans hinge on successful execution of, as some say rollout 2.0, but what about the BP opposition, do you think that they are suddenly going to play nice? The misinformation generators both from other sales reps and the already purchased media will continue to do total destruction of rollout 2.0 - after all its their bread and butter.
|
|
|
Post by dg1111 on May 10, 2016 12:26:23 GMT -5
If it is one buyer, it would put them well over 5% ownership, so we would be seeing a 13-G form.
|
|
|
Post by sweedee79 on May 10, 2016 12:32:36 GMT -5
It reeks of Aegis Capital management... or Rodman & Renshaw or Chardan Capital or some other such small capital management company. Ive been involved with other small bio techs in this position and these guys are often behind the scenes... offering shares at a lower price thus bringing the share price down... happened with SGNL last year.. not sure this is a good thing.. we did get the capital however and BK is off of the table ..
|
|
|
Post by biffn on May 10, 2016 12:47:38 GMT -5
I'm guessing it's Goldman. MNKD is helping them clear their short positions and maybe get them on MNKD's side when things start moving.
|
|
|
Post by dg1111 on May 10, 2016 13:19:52 GMT -5
I'm guessing it's Goldman. MNKD is helping them clear their short positions and maybe get them on MNKD's side when things start moving. This is what I was thinking (or maybe hoping?). Goldman dropped their coverage of MNKD per link posted in Analyst Comment's thread on 3/31. They had to drop the sell rating and 0.25 price target before they bought a bunch of shares. You could say a lot of bad things about Goldman, but I would rather them by on our side than against us.
|
|
|
Post by parrerob on May 10, 2016 13:47:48 GMT -5
I am quite sure the offering is linked with the 10 second silence from Matt yesterday evening.
My movie story tells about Matt advised during the conference of something that happened or did not happened. After that He was thinking about what He could tell or specially what He could not. I don't think the offer was only plan B. Quite sure, imo, the offer had to come out any case (To soon to be a plan B due to an offer dropped). The silence could be related to last minute request of silence from the buyer.
What do You think ? I am watching, again and again, fantasy movies about MNKD ?
|
|
|
Post by mydogskip on May 10, 2016 14:01:01 GMT -5
It reeks of Aegis Capital management... or Rodman & Renshaw or Chardan Capital or some other such small capital management company. Ive been involved with other small bio techs in this position and these guys are often behind the scenes... offering shares at a lower price thus bringing the share price down... happened with SGNL last year.. not sure this is a good thing.. we did get the capital however and BK is off of the table .. It is rodman and renshaw. The big boys won't touch Mannkind.
|
|
|
Post by matt on May 10, 2016 15:24:21 GMT -5
They are all funds that do a series of deals with Rodman & Renshaw. Since they are buying off an S-3 registration the names will not have to be disclosed as "Selling Shareholders" as would be the case with some other registrations, but suffice it to say that these funds make a quick couple of dimes and move on. They are not long-term strategic investors that care about MNKD or its business; they are in it for a quick hit.
|
|
|
Post by sweedee79 on May 10, 2016 21:11:18 GMT -5
I don't like this... These small capital management companies are bad for stocks IMO .. I don't trust them. I don't think this is what Matt wanted to do, but had no choice.
|
|
|
Post by lakon on May 12, 2016 14:07:49 GMT -5
If it is one buyer, it would put them well over 5% ownership, so we would be seeing a 13-G form. Not necessarily, if they already owned over 5%, like the Mann affiliated entities and funds passed the threshold. Then, there's the institutional short covering angle... All good possibilities, now that we know it was a select few, perhaps, even strategic buys. I tried to get in on the deal and was refused -- fully subscribed. Once again, Matt gets picked on, but seems to be honest and unlucky.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 12, 2016 14:09:50 GMT -5
If it is one buyer, it would put them well over 5% ownership, so we would be seeing a 13-G form. Not necessarily, if they already owned over 5%, like the Mann affiliated entities and funds passed the threshold. Then, there's the institutional short covering angle... All good possibilities, now that we know it was a select few, perhaps, even strategic buys. I tried to get in on the deal and was refused -- fully subscribed. Once again, Matt gets picked on, but seems to be honest and unlucky. did u call them to get on it? if so you will get outright rejected
|
|